Forest Laboratories' board approves new 50 million share repurchase program

Forest Laboratories, Inc. (NYSE: FRX) announced today that its Board of Directors has approved a new share repurchase program for up to 50 million shares of its common stock. The authorization will become effective immediately and has no set expiration date. The Company expects to make repurchases from time to time either in the open market or through private transactions, including accelerated share repurchase programs. The program may be suspended or discontinued at any time.

While executing the stock repurchase program, the Company is committed to retaining the financial strength and flexibility it needs to continue to invest in new business development opportunities.

Source:

 Forest Laboratories

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.